Brain Computer Interface Market Is Predicted To Grow Swiftly Due To Enhanced Scope In Medical & Military Till 2022: Grand View Research, Inc.

Global Brain Computer Interface (BCI) Market is expected to reach USD 1.7 billion by 2022, according to a new study by Grand View Research Inc. Increasing incidences of neurodegenerative conditions, advancements in neuroscience, rising geriatric population base and the growing demand for neuroprosthetics are some impact rendering drivers of the brain computer interface market. Furthermore, growing R&D investments and the presence of government projects such as DECODER (European project that used brain computer interface to detect consciousness in non responsive patients) coupled with rising focus of major market players on emerging economies such as Japan and China are also expected to propel market growth over the forecast period. Introduction of technological advancements occurring in the market is expected to result in the availability of better options for healthcare personnel and individuals. The technology encompasses a wide array of applications designed to revolutionize the communication, automation, security and entertainment experience. Brain computer interface is an emerging technology which is currently at a nascent stage; however, the increasing interest among researchers in collaboration with the government is expected to fuel the future growth of this market.

Global brain computer interface market, by application, 2012 - 2022 (USD Million)



Browse full research report on Brain Computer Interface Market Analysis:

Further key findings from the report suggest:

  • Non-invasive BCI is identified as the most lucrative product sub segment of the market and is expected to grow at a rate of over 10.0% over the forecast period majorly owing to, increasing prevalence of paralysis.
  • BCI based healthcare segment accounted for the largest market share in 2014. Rising incidences of brain related disorders, increasing R&D spending over medical applications and growing base of geriatric population are some driving factors for this segment.
  • North America was the largest regional market with a revenue share of over 40.0% in 2014 on account of the presence of an extensive number of ongoing BCI projects. Growing patient awareness level and accessible healthcare infrastructure is also expected to lead to an expedited market growth over the forecast period.  
  • Asia Pacific is identified as the most lucrative regional market. Large presence of untapped opportunities coupled with rapidly improving economic conditions is expected to drive regional market growth over the forecast period. China is expected to witness the fastest growth over the forecast period.
  • Key players of the brain computer interface market include Emotiv System, Mind Solutions Corp., Puzzlebox, Natus Medical, Interactive Productline, Compumedics Ltd. and Neuroelectrics.
 For more information: http://www.grandviewresearch.com


Comments

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.